Sign in

CIK 0000812796

  • Non-accelerated filer
  • Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
411505029
Phone
+1 609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. 4 Open-market buy Chairman, CEO and President bought 10,770 shares at $0.93 ($10,016)
  2. 4 Open-market buy Director bought 14,940 shares at $0.93 ($13,870)
  3. 4 Open-market buy Director bought 4,000 shares at $0.94 ($3,740)
  4. 4 Derivatives Options or other derivatives
  5. 3 Insider Initial Statement of Ownership
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Grant or award Director acquired 78,338 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market buy Director bought 10,000 shares at $0.73 ($7,274)
  15. 4 Open-market buy Chairman, CEO and President bought 5,000 shares at $0.72 ($3,577)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 18 · 344 filings